AU5744490A
(en)
*
|
1989-05-15 |
1990-12-18 |
Afferon Corporation |
Composition and method for neural desensitization
|
US5021450A
(en)
*
|
1989-05-30 |
1991-06-04 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
|
US5232684A
(en)
*
|
1990-06-29 |
1993-08-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Labelled resiniferatoxin, compositions thereof, and methods for using the same
|
WO1992003923A1
(fr)
*
|
1990-08-29 |
1992-03-19 |
THE UNITED STATES OF AMERICA, represented by THE SCRETARY, UNITED STATES DEPARTMENT OF COMMERCE |
Graines pour oiseaux contenant de la capsaicine, ses derives ou ses analogues
|
US5629045A
(en)
*
|
1992-09-17 |
1997-05-13 |
Richard L. Veech |
Biodegradable nosiogenic agents for control of non-vertebrate pests
|
US6063381A
(en)
*
|
1993-05-19 |
2000-05-16 |
Staggs; Jeff J. |
Therapeutic uses of pungent botanicals and their related compounds
|
US6635659B1
(en)
*
|
1995-03-20 |
2003-10-21 |
Arrie Kegler |
Topical formulation for arthritic symptoms treatment
|
US6248788B1
(en)
|
1996-11-06 |
2001-06-19 |
The Regents Of The University Of California |
Therapeutic method with capsaicin and capasicin analogs
|
US6239180B1
(en)
|
1995-11-08 |
2001-05-29 |
The Regents Of The University Of California |
Transdermal therapeutic device and method with capsaicin and capsaicin analogs
|
US5856361A
(en)
*
|
1996-04-23 |
1999-01-05 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US5869533A
(en)
*
|
1996-04-23 |
1999-02-09 |
Holt; Stephen D. |
Non-irritating capsaicin formulations and applicators therefor
|
CA2264739C
(fr)
*
|
1996-09-05 |
2008-03-18 |
Research Development Foundation |
Inhibition du facteur de transcription nucleaire nf-kb par l'ester phenethylique d'acide cafeique, les derives de cet ester, la capsaicine (8-methyl-n-vanillyle-6-noneamide) et laresiniferatoxine
|
AU5460598A
(en)
*
|
1996-11-15 |
1998-06-03 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
|
DK0998288T4
(da)
†
|
1997-03-13 |
2005-08-22 |
James N Campbell |
Sammensætninger indeholdende kapasaicin eller kapsaicinanaloge og et lokalbedövelsesmiddel
|
WO1999009970A1
(fr)
*
|
1997-08-28 |
1999-03-04 |
Afferon Corporation |
Therapie contre l'incontinence urinaire
|
US6790207B2
(en)
|
1998-06-04 |
2004-09-14 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
|
US20110071468A1
(en)
*
|
1998-06-04 |
2011-03-24 |
Mederi Therapeutics, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US6802841B2
(en)
*
|
1998-06-04 |
2004-10-12 |
Curon Medical, Inc. |
Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
|
US6197823B1
(en)
|
1999-09-29 |
2001-03-06 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
US6348501B1
(en)
|
1999-09-29 |
2002-02-19 |
Medical Merchandising, Inc. |
Lotion compositions utilizing capsaicin
|
US6653352B2
(en)
|
1999-09-29 |
2003-11-25 |
Medical Merchandising, Inc. |
Pain reliever and method of use
|
EP1301484A2
(fr)
*
|
2000-07-20 |
2003-04-16 |
Neurogen Corporation |
Ligands du recepteur de la capsicine
|
US20040146590A1
(en)
*
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
US20060240125A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Astrup Arne V |
Composition for affecting weight loss
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
CN1627944A
(zh)
*
|
2002-01-17 |
2005-06-15 |
神经能质公司 |
取代的喹唑啉-4-基胺类似物作为辣椒辣素调节剂
|
US20040126430A1
(en)
*
|
2002-09-05 |
2004-07-01 |
Angel Arturo J. |
Compositions and kits for the removal of irritating compounds from bodily surfaces
|
EP2422775A3
(fr)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Séquestration de sous-unité et compositions et procédés associés
|
US20040191338A1
(en)
*
|
2002-12-18 |
2004-09-30 |
Algorx |
Administration of capsaicinoids
|
PT1605956E
(pt)
|
2002-12-18 |
2016-03-09 |
Centrexion Therapeutics Corp |
Administração de capsaicinóides para o tratamento da osteoartrite
|
BRPI0409748A
(pt)
*
|
2003-04-08 |
2006-10-24 |
Algorx Pharmaceuticals Inc |
preparação e purificação de capsaicin sintetico
|
US20040224037A1
(en)
*
|
2003-04-28 |
2004-11-11 |
Gonzalo Romero-Matos |
Devastating treatment against hiv/aids with capsaicin
|
CA2529984C
(fr)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
CA2596194A1
(fr)
*
|
2004-11-24 |
2006-06-01 |
Algorx Pharmaceuticals, Inc. |
Formulation a base de capsaicinoide en gel et utilisations afferentes
|
CA2594202C
(fr)
*
|
2004-12-28 |
2013-12-03 |
Mestex Ag |
Utilisation de la resiniferatoxine (rtx) pour produire un agent servant a traiter des douleurs articulaires, et procede d'administration de cet agent
|
NZ556261A
(en)
*
|
2005-01-28 |
2012-04-27 |
Adm Alliance Nutrition Inc |
Animal feed compositions capable of reducing the incidence of fescue toxicosis in mammas containing a coated or encapsulated capsaicin product and an adsorbant
|
WO2006107723A1
(fr)
*
|
2005-04-01 |
2006-10-12 |
Neurogesx, Inc. |
Huiles de capsaicinoides et leurs methodes de conception et d'utilisation
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
BRPI0708716A2
(pt)
*
|
2006-03-10 |
2011-06-07 |
Archer Daniels Midland Co |
métodos e composições para produtividade aumentada em animais
|
EP2007360B1
(fr)
*
|
2006-04-03 |
2014-11-26 |
Isa Odidi |
Dispositif d'administration à libération commandée comprenant un enrobage organosol
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
CA2655835C
(fr)
|
2006-06-19 |
2015-07-21 |
Alpharma, Inc. |
Compositions pharmaceutiques d'agonistes opioides resistants a l'abus
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
WO2008109026A1
(fr)
*
|
2007-03-05 |
2008-09-12 |
Mt Cook Pharma |
Compositions pharmaceutiques pour traitement localisé d'un dysfonctionnement neurogénique
|
US8233976B2
(en)
|
2007-12-05 |
2012-07-31 |
The Invention Science Fund I, Llc |
System for transdermal chemical modulation of neural activity
|
US8165668B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
Method for magnetic modulation of neural conduction
|
US8989858B2
(en)
*
|
2007-12-05 |
2015-03-24 |
The Invention Science Fund I, Llc |
Implant system for chemical modulation of neural activity
|
US8180446B2
(en)
*
|
2007-12-05 |
2012-05-15 |
The Invention Science Fund I, Llc |
Method and system for cyclical neural modulation based on activity state
|
US8165669B2
(en)
|
2007-12-05 |
2012-04-24 |
The Invention Science Fund I, Llc |
System for magnetic modulation of neural conduction
|
US8170659B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
Method for thermal modulation of neural activity
|
US20090149799A1
(en)
*
|
2007-12-05 |
2009-06-11 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Method for chemical modulation of neural activity
|
US8170658B2
(en)
*
|
2007-12-05 |
2012-05-01 |
The Invention Science Fund I, Llc |
System for electrical modulation of neural conduction
|
US8195287B2
(en)
|
2007-12-05 |
2012-06-05 |
The Invention Science Fund I, Llc |
Method for electrical modulation of neural conduction
|
US8987328B2
(en)
|
2008-10-30 |
2015-03-24 |
Trinity Laboratories, Inc. |
Esters of capsaicinoids as dietary supplements
|
US20100303932A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Baskaran Thyagarajan |
Method for Attenuating the Effects of Botulinum Toxin
|
WO2011044381A1
(fr)
*
|
2009-10-07 |
2011-04-14 |
Inflasoothe, Inc. |
Composition, système et procédé pour soulager la douleur
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US20130247383A1
(en)
|
2010-07-19 |
2013-09-26 |
3M Innovative Properties Company |
Hand tool with replaceable knife cartridge
|
DK2629610T3
(da)
|
2010-07-27 |
2017-11-20 |
Flex Pharma Inc |
Fremgangsmåder og sammensætninger til forebyggelse og lindring af muskelkramper og til rehabilitering fra neuromuskulær irritabilitet og træthed efter træning
|
DK2826467T3
(en)
|
2010-12-22 |
2017-10-16 |
Purdue Pharma Lp |
INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS
|
CN107412173A
(zh)
|
2010-12-23 |
2017-12-01 |
普渡制药公司 |
抗篡改固体口服剂型
|
AU2014215478B2
(en)
|
2013-02-05 |
2018-09-13 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
CA2910865C
(fr)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions et methodes destines a reduire les surdoses
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
US11253493B2
(en)
|
2017-01-23 |
2022-02-22 |
Cliff-Cartwright Corporation |
Compositions and methods affecting exercise performance
|
US11707437B2
(en)
|
2019-07-12 |
2023-07-25 |
Board Of Trustees Of Southern Illinois University |
Topical formulations with resiniferatoxin nanoparticles and methods
|